HSE approves new treatment option for people with breast cancer at high-risk of recurrence
The Health Service Executive (HSE) has approved a new treatment option for people with breast cancer at high-risk of recurrence, which could reduce the chance of their cancer returning by more than 30 per cent. The drug, called abemaciclib, will be given …